West Pharmaceutical Services Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 16, 2023 / 10:00PM GMT
John Newton Sourbeer - UBS Investment Bank, Research Division - Equity Research Associate

So thanks for -- welcome to the UBS 2023 conference here. I'm John Sourbeer, UBS's life science analyst. Happy to host the fireside today with West Pharmaceuticals. Joining me is CEO and President, Eric Green; and VP of Investor Relations, Quintin Lai. Thanks for attending here.

Eric M. Green - West Pharmaceutical Services, Inc. - Chair, President & CEO

Yes, John, thanks for having us. It's been a really good day here at UBS. So thank you.

Questions and Answers:

John Newton Sourbeer - UBS Investment Bank, Research Division - Equity Research Associate

Great. So maybe start off here, high-level question. I know you guys reported earnings a couple of weeks ago, but on the demand environment, the company continues to see strong demand really across this proprietary product segment and the broader portfolio despite macro headwinds seen by peers and others within biologics or [larger] biopharma life science tools. So I guess
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot